The 8 references in paper Е. Баранова И., А. Соболева В., Р. Азнаурян С., В. Ионин А., Е. Чубенко А., А. Кацап А., Д. Яцук И., Е. Баранова И., А. Соболева В., Р. Азнаурян С., В. Ионин А., Е. Чубенко А., А. Кацап А., Д. Яцук И. (2015) “АДЕКВАТНОСТЬ АНТИТРОМБОТИЧЕСКОЙ ТЕРАПИИ ПРИ НЕКЛАПАННОЙ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ В РЕАЛЬНОЙ КЛИНИЧЕСКОЙ ПРАКТИКЕ” / spz:neicon:aterotromboz:y:2015:i:1:p:16-23

1
Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation, 2014, 25, 129(8): 837–847. doi: 0.1161/CIRCULATIONAHA.113.005119. Epub 2013 Dec 17.
(check this in PDF content)
2
Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke, 1991, 22(8): 983–988.
(check this in PDF content)
3
Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J,2012, 33: 2719–2747.
(check this in PDF content)
4
Диагностика и лечение фибрилляции предсердий. Рекомендации РКО, ВНОА, АССХ 2012. Российский кардиологический журнал, 2013, 4(102): приложение 3.
(check this in PDF content)
5
Kirchhof P, Ammentorp B, Darius H, De Caterina R, Le Heuzey JY, Schilling RJ et al. Management of atrial fibrillation in seven European countries after the publication of the 2010 Guidelines on atrial fibrillation. Primary results of the prevention of the thromboembolic events — European Registry in Atrial Fibrillation (PREFER in AF). Europace, 2014, 16(1): 6–14.
(check this in PDF content)
6
Бойцов С.А., Якушин С.С., Марцевич С.Ю. Амбулаторно-поликлинический регистр кардиоваскулярных заболеваний в Рязанской области (РЕКВАЗА): основные задачи, опыт создания и первые результаты. Рациональная фармакотерапия в кардиологии, 2013, 9 (1): 4–14.
(check this in PDF content)
7
Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J et al. EHRA Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary. Eur Heart J,2013, 34: 2094–2106.
(check this in PDF content)
8
Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a metaanalysis of randomised trials. Lancet,2014, 383(9921):
(check this in PDF content)